Sarah-Jo Sinnott, MPharm, PhD

Director, Pharmacoepidemiology
Sanofi
cambridge, United States

safety pharmacoepi

Disclosure information not submitted.

Presentation(s):

• Conjunctivitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States

  Tuesday, August 27, 2024
  1:45 PM – 2:00 PM CEST